跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Mefesaph
Approved
STANDARD
Mefesaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
010ab826ae977c68
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
010ab826ae977c68
Drug Approval Philippines Name
Mefesaph
Product Name
Mefesaph
Registration Number
DRP-5836
Brand Name
Mefesaph
Generic Name
Mefenamic Acid
Dosage Form
Tablet
Dosage Strength
500 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
28 September 2024
Expiry Date
04 December 2029
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
010ab826ae977c68
Type
Standard
Back to Philippines FDA Approvals
Mefesaph - Philippines FDA Drug Approval Details